Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease

ClinicalTrials.gov ID: NCT00559871

Public ClinicalTrials.gov record NCT00559871. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 2:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose Response Study of the Efficacy, Safety and Tolerability of Fipamezole as an Oromucosal Fast Dissolving Tablet in the Treatment of Parkinson's Disease Patients.

Study identification

NCT ID
NCT00559871
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Juvantia Pharma Ltd
Industry
Enrollment
180 participants

Conditions and interventions

Interventions

  • fipamezole Drug

Drug

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2007
Primary completion
Apr 30, 2009
Completion
Apr 30, 2009
Last update posted
Jun 2, 2009

2007 – 2009

United States locations

U.S. sites
29
U.S. states
19
U.S. cities
28
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
Neurology Clinic PC Northport Alabama 35476
University of Arizona Health Sciences Center Tucson Arizona 85724-5023
Parkinson and Movement Disorder Institute Fountain Valley California 92708
University of California Irvine Irvine California 92697
Coastal Neurological Medicine Group La Jolla California 92037
Colorado Neurological Institute Englewood Colorado 80113
Parkinson's Disease and Movement Disorder Center Boca Raton Florida 33486
Sunrise Clinical Research Hollywood Florida 33021
Pharmax Research Clinic Miami Florida 33126
University of Miami Miami Florida 33136
Collier Neurological Clinic Naples Florida 34102
University of South Florida, Parkinson's Disease and Movement Center Tampa Florida 33606
Emory Healthcare Atlanta Georgia 30329
Medical College of Georgia Augusta Georgia 30912
Rush University Medical Center Chicago Illinois 60612
Parkinson Disease Center - University of Kansas Medical Center Kansas City Kansas 66160
Ochsner Clinic Foundation New Orleans Louisiana 70121
Maryland Parkinson's Disease and Movement Disorder Center Baltimore Maryland 21201
U Mass Memorial Medical Center Worcester Massachusetts 01655-0318
Henry Ford Health Systems, Franklin Pointe Medical Center Southfield Michigan 48034
Struthers Parkinson's Center Golden Valley Minnesota 55427
Neurology Group of Bergen County Ridgewood New Jersey 07450
Biomedical Research Alliance of New York Forest Hills New York 11375
Duke Health Center at Morreene Road Durham North Carolina 27705
Oregon Health and Science University Portland Oregon 97239-3098
Semmes Murphey Neurologic and Spine Institute Memphis Tennessee 38104
Baylor College of Medicine Houston Texas 77030
Neurology Associates San Antonio Texas 78258

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00559871, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 2, 2009 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00559871 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →